The SUSTAIN clinical trial program, which evaluated semaglutide in over 8,000 patients with type 2 diabetes, consistently showed improvements in HbA1c, fasting plasma glucose, and body weightall indirect indicators of improved insulin sensitivity
Research has shown that GH increases the mobilization of free fatty acids from adipose tissue and shifts metabolism toward fat oxidation (9)
Moreover, clinical trials have reported a reduction of the inflammatory C-reactive protein (70), which could indicate that this drug may also regulate the immune system, although this approach requires further assessment
These medications are contraindicated in pregnancy and also while breastfeeding
Mass pharmacological weight loss is not only a health shock
Neither can plant protein